Home

Jenburkt Pharmaceuticals Ltd EPS

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

EPS

₹ 72.65

Last updated on: May 30, 2025

Key Highlights

  • The Earning per Share of Jenburkt Pharmaceuticals Ltd is ₹ 72.65 as of 30 May 25 .
  • The earning per share of Jenburkt Pharmaceuticals Ltd changed from ₹ 12.17 to ₹ 19.34 over 8 quarters. This represents a CAGR of 26.06% .

Historical Earning per Share of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

500 Cr

EPS

72.7

P/E Ratio (TTM)

15.6

P/B Ratio (TTM)

2.9

Day’s High

1164.8

Day’s Low

1127.3

DTE

0.0

ROE

18.7

52 Week High

1375.0

52 Week Low

735.2

ROCE

24.8

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 May 20251133.9
29 May 20251145.75
28 May 20251166.45
27 May 20251166.25
26 May 20251181
23 May 20251174
22 May 20251153.85
21 May 20251151.5
20 May 20251131.75
19 May 20251100.9

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Jenburkt Pharmaceuticals Ltd

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

500

Asset Value

Value addition

3.5 X

112

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Jenburkt Pharmaceuticals Ltd500.42
Sun Pharmaceutical Industries Ltd402680
Divis Laboratories Ltd175532
Cipla Ltd118307
Torrent Pharmaceuticals Ltd107416
Dr Reddys Laboratories Ltd104453

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to hold AGM

Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be

Read more

21 May 25

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Jenburkt Pharmaceuticals Ltd

What is the EPS of Jenburkt Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Jenburkt Pharmaceuticals Ltd is 72.65. An EPS is the amount of net income attributed to each share of a common stock.

How is Jenburkt Pharmaceuticals Ltd EPS calculated?

The EPS of Jenburkt Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Jenburkt Pharmaceuticals Ltd report its EPS?

Jenburkt Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Jenburkt Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Jenburkt Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Jenburkt Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Jenburkt Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions